Kidney disease Board decisions

The Veteran's hypertension is granted service connection under the PACT Act, and his cystic kidney disease is granted as secondary to his service-connected hypertension.

The Board has granted an effective date of February 22, 2016 for the award of service connection for right kidney cancer based on in-service exposure to ionizing radiation.

The Board has remanded the Veteran's claims for hearing loss and kidney disability due to a lack of current VA examination, failure to report for scheduled examinations, and inadequate opinions in previous examinations.

The Veteran's claims for service connection and compensation under 38 U.S.C. § 1151 are remanded due to concerns about the adequacy of medical care provided, including delayed diagnosis of hyperaldosteronism.

The Veteran's claims for service connection and compensation under 38 U.S.C. § 1151 are remanded due to concerns about the adequacy of VA treatment and potential delays in diagnosis.

The Veteran's death was caused by end stage renal disease, which the VA clinician concluded was due to his hypertension. The private clinician opined that the Veteran's exposure to Agent Orange in service, along with service-connected PTSD, caused the development of his hypertension and contributed substantially to his end stage renal disease.

The Veteran's service-connected chronic kidney disease and residuals of kidney cancer are granted, with a 60% rating for the latter condition.

The Board has remanded the claims for service connection for lumbosacral radiculopathy disorder and chronic kidney disease due to a lack of an adequate VA examination. The Veteran's participation in toxic exposure risk activities is conceded.

The Veteran's skin cancer and associated scars are not rated higher than noncompensable.,The Veteran's left adrenal gland adenoma, prostate cancer, and erectile dysfunction do not have a service connection due to lack of continuity of symptoms since service or evidence of a nexus with service.,Service connection for the acquired psychiatric disorder (major depressive disorder single episode unspecified and anxiety disorder unspecified) is granted.

The Veteran's cause of death, metastatic kidney cancer, is found to be service-connected due to presumed exposure to herbicide agents in Vietnam. Service connection for the cause of death is granted.

The Veteran's claims for service connection for asthma and kidney stones have been granted. The appeals for service connection for CFS, strep throat, bilateral hearing loss, bronchitis, and fibromyalgia were dismissed due to the Veteran withdrawing his appeal.

The Veteran's PTSD and Chronic Kidney Disease ratings have been restored to their previous levels of 70% and 30%, respectively, due to the failure to conduct necessary VA examinations in November 2019.

The Board has remanded the claims for hypertension and kidney failure due to potential exposure to herbicides during service. The appellant must provide a new TERA memorandum addressing his claimed exposure, specifically considering the January 2024 Gagetown Commission Report.

The Board has remanded the claims of entitlement to service connection for right knee meniscal tear, chronic kidney disease, and an initial rating in excess of 10 percent for right foot plantar fasciitis due to lack of new and relevant evidence.

The Board has determined that the severance of service connected death benefits was improper and grants the appeal.

The Board dismissed the appeal regarding an earlier effective date for scleroderma renal crisis due to a procedural defect, as the Veteran's VA Form 10182 was not validly opted into the AMA review system.

The Veteran's service connection claims for GERD, hypertension, obstructive sleep apnea, atrial fibrillation, diabetes mellitus type II, and kidney disease have all been denied as there is no credible evidence linking these conditions to his military service.

The Veteran's death was caused by end stage renal disease, which the VA clinician concluded was due to his hypertension. The private clinician opined that the Veteran's exposure to Agent Orange in service, along with service-connected PTSD, caused the development of his hypertension and contributed substantially to his end stage renal disease.

The Board has determined that new and relevant evidence has been received to readjudicate the previously denied claims of service connection for hypertension and kidney failure. The AOJ is required to consider this new evidence in deciding these claims.

The Veteran's kidney/renal failure, which could have been service-connected, contributed to his death. The Board has granted service connection for the cause of death.